The U.S.-China riff grows over Covid — Texas House race revives Trump team rivalries — Democrats mull new health insurance options

From: POLITICO Pulse - Monday Apr 12,2021 02:09 pm
Presented by UnitedHealth Group: Delivered daily by 10 a.m., Pulse examines the latest news in health care politics and policy.
Apr 12, 2021 View in browser
 
POLITICO's Pulse newsletter logo

By Sarah Owermohle and Adam Cancryn

Presented by

Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care's morning newsletter, which is delivered to our s each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories. Act on the news with POLITICO Pro.

Quick Fix

— The rift between the U.S. and China keeps widening as questions mount about global vaccination efforts.

— Former HHS official Brian Harrison’s run for a Texas House seat has rekindled old feuds between some Trump-era health officials.

— Democrats are considering how to offer health insurance to poor adults in states that opted out of Medicaid expansion.

WELCOME TO MONDAY PULSE. Fact check: This tweet is attacking us and our bookshelves. Send tips to sowermohle@politico.com and Adam at acancryn@politico.com.

A message from UnitedHealth Group:

Medicare Advantage beneficiaries spend 40% less in premiums and out-of-pocket costs, and get more benefits, than those covered by Medicare Fee-for-Service. Our new report shows how Medicare Advantage is delivering better value for 26 million Americans at a lower cost. Learn more.

 
Driving the Day

CHINA TENSIONS RISE OVER COVID — China needs to own up to its early failings in the Covid-19 pandemic, according to Secretary of State Antony Blinken, who said Sunday that the world still needs "to get to the bottom of" the origins of the virus.

"China knows that in the early stages of Covid, it didn't do what it needed to do, which was to, in real time, give access to international experts, in real time to share information, in real time to provide real transparency," Blinken said on NBC's "Meet the Press."

A World Health Organization report released last month acknowledged that WHO's investigators had been unable to fully solve questions about the origins of the pandemic, but also said that one widespread if unproven theory — that the virus escaped from a Chinese lab — is “extremely unlikely.” Still, WHO said it had difficulties getting its team on the ground in China and getting full access, leading Blinken and other officials, such as national security adviser Jake Sullivan, to voice concerns about the virus’s origins before the report’s release.

Meanwhile, a top Chinese health official opened up about the country’s vaccination efforts over the weekendand the news isn’t great. The official, Gao Fu, said on Sunday that China’s two Covid vaccines, from Sinovac and Sinopharm, “don’t have very high protection rates,” according to the Associated Press’ Joe McDonald and Huizhong Wu. The government is considering mixing them to boost protection, he added.

The problem: China has distributed hundreds of millions of shots to other countries. One of them, the United Arab Emirates, last month signed up to be a major production hub of the Sinopharm shot with the expectation that UAE will provide millions more doses around the region.

There still are not many options for global vaccination. AstraZeneca has supplied hundreds of millions of doses worldwide, but some countries have stalled its administration amid safety concerns and questions about its efficacy against certain strains. Novavax has also promised to deliver huge supplies around the world, but it’s not ready to file its vaccine for approval just yet.

Orders are flowing for a Russian Covid shot, known as Sputnik V. Germany, the Czech Republic and others are in talks to buy some; Austria just finished negotiations for its own batch, and Hungary is administering doses now. But European drug regulators still have not reviewed the shot and Russia hasn’t submitted it for approval, though the bloc said this weekend it will begin monitoring the shot’s safety, as our POLITICO Europe colleagues report.

TEXAS RACE REVIVES TRUMP TEAM RIVALRIESHarrison’s run in the crowded field for an open Texas House seat has prompted complaints from other Trump-era alumni and sparked a behind-the-scenes effort to dent his candidacy, Adam reports.

Harrison, former chief of staff to then-HHS Secretary Alex Azar, has rhetorically lashed himself to former President Donald Trump, touting his work during the administration on the Covid vaccine sprint and a range of other health care initiatives.

But that’s angered some former White House and HHS appointees, who clashed with Harrison repeatedly over the past four years and viewed him as a driver of conflict that hampered Trump’s policy ambitions.

One top Trump HHS official, Roger Severino, has endorsed one of Harrison's opponents. Others have worked to slow Harrison’s momentum, including by counseling Trump not to back him in the race. They argue that Harrison has taken too much credit for Trump’s anti-abortion legacy, and that the deregulatory moves he’s touted on the trail were divisive and ineffectual.

Harrison brushed off the criticism in an interview, pointing to a series of donations from other Trumpworld figures, like former Education Secretary Betsy DeVos, former Small Business Administration chief Linda McMahon and tech billionaire and Trump ally Peter Thiel. Overall, he’s raised more than $600,000 ahead of the May 1 special election.

His candidacy, though, is fueling a broader debate among Trump alums over who should get to carry the former president’s mantle during Biden’s term and beyond. Trump himself is steering clear of endorsing anyone in the race for now, according to his senior adviser, Jason Miller.

 

SUBSCRIBE TO "THE RECAST" TO JOIN AN IMPORTANT CONVERSATION: Power is changing, in Washington and across the country. More people are demanding a seat at the table, insisting that all politics is personal and not all policy is equitable. Our twice-weekly newsletter "The Recast” breaks down how race and identity are shaping politics and policy in America and we are recasting how we report on it. Get fresh insights, scoops and dispatches on this crucial intersection from across the country and hear from important new voices that challenge business as usual. Don't miss out, SUBSCRIBE . Thank you to our sponsor, Intel.

 
 


In Congress

DEMOCRATS PURSUE MORE COVERAGE OPTIONS FOR POOR ADULTS — The Biden administration and Democratic leaders in Congress want to use their upcoming infrastructure package to provide health insurance to poor adults in states that have rebuffed Medicaid expansion, two senior Democratic aides tell our Susannah Luthi.

The effort would amount to an end-run around longstanding GOP opposition to expanding health coverage in a dozen holdout states — a stance that has left more than 2 million people there without access to affordable coverage.

Talks over the spending package have only just begun, but policy experts have floated two options: a federal program aimed at holdout states or a new round of Affordable Care Act subsidies targeted at people below the poverty line. A Biden administration spokesperson didn’t comment on the effort, but pointed to President Joe Biden’s campaign platform, which supports adding coverage for this population.

 

Advertisement Image

 
White House

ICYMI: BIDEN BUDGET WOULD BOOST HEALTH AGENCIES — Federal health agencies stand to win a 23 percent funding increase under Biden’s fiscal 2022 budget blueprint which includes a bump in CDC funding and ambitious research plans for the National Institutes of Health, our Adriel Bettelheim outlines.

The highlights:

— An extra $1.6 billion for CDC to upgrade its public health data collection efforts and build capacity to respond to global health threats;

— Billions to NIH, including $6.5 billion to establish an Advanced Research Projects Agency for Health, which will initially focus on cancer, diabetes and Alzheimer's research;

— A $905 million infusion into the national stockpile to replenish medical supplies.

— Additional funding aimed at issues unrelated to Covid, like mental health research, the opioid crisis response and HIV/AIDS support.

Around the World

ANOTHER COVID VACCINE POISED FOR SUMMER USE — Germany’s CureVac hopes its coronavirus vaccine will get the green light from the European Medicines Agency in May or June, a company spokesperson said this weekend.

“We are already very advanced in the third clinical test phase and are awaiting the data for the final approval package,” company spokesperson Thorsten Schüller told the Augsburger Allegemeine newspaper in an interview published on Saturday.

Schüller confirmed earlier plans to produce up to 300 million doses this year, working with Bayer and other partners to meet production targets, POLITICO Europe’s Ashleigh Furlong reports.

Meanwhile: Tesla CEO Elon Musk tweeted — then quickly deleted — a hint about CureVac’s timeline on Friday, speculating that “a tidal wave of vaccine is coming this summer.” Tesla partnered with CureVac last summer to mass produce its vaccine ingredients.

A message from UnitedHealth Group:

A new report shows that a Medicare Advantage beneficiary can save up to $99,000 over 21 years compared to those in Medicare Fee-for-Service, while receiving more services like meals, transportation and care coordination. That’s one reason why 26 million Americans who have chosen Medicare Advantage give it a 98% satisfaction rating. Find out more.

 
What We're Reading

A Georgia vaccine site temporarily shut down this weekend after reports of rare side effects from the Johnson & Johnson vaccine, the third facility to do so after Colorado and North Carolina sites also suspended the shots last week, CBS News’ Nikki Battiste reported. The other sites resumed vaccinations this weekend.

The recent racism-in-medicine fiasco at prominent medical journal JAMA betrays a larger lack of diversity among prestigious journals’ staff, STAT’s Usha Lee McFarling writes.

Former Oregon Gov. John Kitzhaber wrote about how to achieve universal health coverage, suggesting that the Biden administration can swerve past congressional gridlock and use state CMS models as proofs of concept.

 

TUNE IN TO GLOBAL TRANSLATIONS: Our Global Translations podcast, presented by Citi, examines the long-term costs of the short-term thinking that drives many political and business decisions. The world has long been beset by big problems that defy political boundaries, and these issues have exploded over the past year amid a global pandemic. This podcast helps to identify and understand the impediments to smart policymaking. Subscribe and start listening today.

 
 
 

Follow us on Twitter

Joanne Kenen @joannekenen

Adriel Bettelheim @abettel

Jason Millman @jasonmillman

Lauren Morello @lmorello_dc

Sara Smith @sarasmarley

Adam Cancryn @adamcancryn

Tucker Doherty @tucker_doherty

Dan Goldberg @dancgoldberg

David Lim @davidalim

Susannah Luthi @SusannahLuthi

Alice Miranda Ollstein @aliceollstein

Sarah Owermohle @owermohle

Carmen Paun @carmenpaun

Mohana Ravindranath @ravindranize

Rachel Roubein @rachel_roubein

Darius Tahir @dariustahir

Erin Banco @ErinBanco

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings

This email was sent to by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Please click here and follow the steps to .

More emails from POLITICO Pulse